DTC genomic tests: Some patients dissatisfied with physician interpretation
Twenty-seven percent of patients who purchased direct-to-consumer personal genomic testing in a large cohort study shared their results with their primary care providers, often looking for him or her... (Source: Rheumatology News)
Source: Rheumatology News - February 29, 2016 Category: Rheumatology Source Type: research
VIDEO: Beware legal land mines when working with PAs, NPs
AUSTIN, TEX. – As use of mid-level providers grows, legal risks for practices also can rise.
In this video interview at an American Health Lawyers Association conference, attorney <a... (Source: Rheumatology News)
Source: Rheumatology News - February 25, 2016 Category: Rheumatology Source Type: research
2015 ACR RA guidelines criticized on steroid, HBV screening, cancer history advice
Rheumatologists have criticized what they described as omissions and problems with the 2015 American College of Rheumatology guidelines for treating rheumatoid arthritis.
Although the authors... (Source: Rheumatology News)
Source: Rheumatology News - February 25, 2016 Category: Rheumatology Source Type: research
Once-daily tofacitinib formulation gets FDA clearance for RA
The Food and Drug Administration has approved a once-daily, extended-release tablet formulation of tofacitinib 11 mg, the drug’s manufacturer, Pfizer, announced.
The Janus kinase inhibitor, to be... (Source: Rheumatology News)
Source: Rheumatology News - February 25, 2016 Category: Rheumatology Source Type: research
AMA’s Stack ‘cautiously optimistic’ about MACRA implementation
WASHINGTON – Coming regulations to implement the MACRA legislation also could include sweeping reforms to meaningful use and quality reporting programs, said Dr. Steven J. Stack, president of the... (Source: Rheumatology News)
Source: Rheumatology News - February 24, 2016 Category: Rheumatology Source Type: research
NNTs show once-unimaginable psoriasis outcomes now readily attainable
WAIKOLOA, HAWAII – Scrutiny of the number needed to treat with various systemic drugs to achieve a Psoriasis Area and Severity Index–90 (PASI-90) response in psoriasis highlights the folly of current... (Source: Rheumatology News)
Source: Rheumatology News - February 24, 2016 Category: Rheumatology Source Type: research
Dr. Robert Califf confirmed as FDA commissioner
Dr. Robert M. Califf was confirmed as Commissioner of the Food and Drug Administration by an 89-4 vote of the full Senate on Feb. 24.
Physician associations praised the Senate’s confirmation,... (Source: Rheumatology News)
Source: Rheumatology News - February 24, 2016 Category: Rheumatology Source Type: research
Registry shows no increased cancer risk with biologics for psoriasis
WAIKOLOA, HAWAII – The latest update from the ongoing PSOLAR registry provides “very reassuring” evidence that the use of biologic agents to treat moderate to severe psoriasis doesn’t significantly... (Source: Rheumatology News)
Source: Rheumatology News - February 24, 2016 Category: Rheumatology Source Type: research
Prednisolone, indomethacin similarly effective for acute gout
Oral prednisolone is as effective as indomethacin for relieving pain in acute gout and should be considered a first-line treatment option, according to a report published online Feb. 22 in Annals of... (Source: Rheumatology News)
Source: Rheumatology News - February 22, 2016 Category: Rheumatology Source Type: research
Rheumatic problems plague chikungunya patients
Approximately one-third of chikungunya patients who acquired the disease during Caribbean travel reported postchikungunya muscle pain, joint pain, and joint swelling, according to data for 28... (Source: Rheumatology News)
Source: Rheumatology News - February 19, 2016 Category: Rheumatology Source Type: research
Investigators recover nearly $755 million in health fraud
Government investigators recovered nearly $755 million in criminal and civil health fraud actions in 2015, according to new figures from the Health & Human Services Office of Inspector General... (Source: Rheumatology News)
Source: Rheumatology News - February 19, 2016 Category: Rheumatology Source Type: research
Ultrasound could help identify patients suitable for biologic tapering
Ultrasound evaluation at the time of clinical remission could be a useful tool to select the most appropriate rheumatoid arthritis (RA) patients to undergo biologic therapy tapering and... (Source: Rheumatology News)
Source: Rheumatology News - February 18, 2016 Category: Rheumatology Source Type: research
Supreme Court: Fate of health care cases uncertain after Scalia death
The fate of several high-profile health care cases remains uncertain after the death of U.S. Supreme Court Justice Antonin Scalia.
The eight remaining justices will hear oral arguments on and weigh... (Source: Rheumatology News)
Source: Rheumatology News - February 18, 2016 Category: Rheumatology Source Type: research
NSAIDs effective and safe for axSpA in the short term
The findings of a recent Cochrane review back up guidelines that recommend NSAIDs as an appropriate first-line treatment for people with axial spondyloarthritis (axSpA).
NSAIDs have been associated... (Source: Rheumatology News)
Source: Rheumatology News - February 18, 2016 Category: Rheumatology Source Type: research
Change to NPDB guidebook redefines ‘investigation’
AUSTIN, TEX. – Physicians could face more reportable actions to the National Practitioner Data Bank (NPDB) under changes to the data bank’s guidebook.
In its last update of the guidebook, the Health... (Source: Rheumatology News)
Source: Rheumatology News - February 17, 2016 Category: Rheumatology Source Type: research
